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Abstract A competitive lateral ﬂow assay for detecting
the major peanut allergen, Ara h1, has been developed.
The detector reagents are Ara h1-tagged liposomes, and
the capture reagents are anti-Ara h1 polyclonal anti-
bodies. Two types of rabbit polyclonal antibodies were
raised either against the entire Ara h1 molecules (anti-
Ara h1 Ab) or against an immunodominant epitope on
Ara h1 (anti-peptide Ab). All of them reacted speciﬁcally
with Ara h1 in Western Blot against crude peanut pro-
teins. Moreover, the anti-Ara h1 Ab was chosen for this
assay development because of its highest immunoactiv-
ity to Ara h1-tagged liposomes in the lateral ﬂow assay.
The calculated limit of detection (LOD) of this assay is
0.45 lg mL1 of Ara h1 with a dynamic range between
0.1 and 10 lg mL1 of Ara h1 in buﬀer. Additionally,
the visually determined detection range is from 1 to
10 lg mL1 of Ara h1 in buﬀer. Results using this assay
can be obtained within 30 min without the need of
sophisticated equipment or techniques; therefore, this
lateral ﬂow assay has the potential to be a cost-eﬀective,
fast, simple, and sensitive method for on-site screening
of peanut allergens.
Keywords Ara h1 Æ Lateral ﬂow assay Æ Liposomes Æ
Peanuts Æ Peanut allergen
Introduction
Peanut allergy is a serious health problem in westernized
countries because of its low outgrowth and life-threat-
ening character [1]. Recent studies indicated that
approximately 1 in 150–200 individuals has peanut al-
lergy in these countries [2–4]. Moreover, the prevalence
of peanut allergy seems to be increasing, which suggests
that peanut allergy is a growing problem [5, 6]. In a
double-blind placebo-controlled food-challenge
(DBPCFC) study, mild allergic symptoms were reported
with a dose as little as 100 lg of peanut proteins [7].
However, no immunotherapy has been successfully
developed for treating peanut allergy. The only eﬀective
way to prevent adverse allergic reactions is strict
avoidance of peanut allergens. Usually, the accidental
exposures of peanut allergens are due to the contami-
nation of peanuts in production lines or in raw materi-
als, or the presence of undeclared allergens in products
such as cereals, cookies, cakes, and snacks [8]. There-
fore, development of a portable, rapid, reliable, and
sensitive assay to detect hidden peanut allergens is an
urgent requirement. This development can increase food
safety for peanut-allergic patients.
The methods to detect peanut contamination can be
classiﬁed into two groups: protein-based or DNA-based.
Protein-based methods either detect major peanut
allergens, such as Ara h1 or Ara h2, or detect the entire
peanut proteins [9]. Protein-based methods include en-
zyme-linked immunosorbent assay (ELISA) [10], rocket
immuno-electrophoresis (RIE) [11], dot immunoblotting
[8, 12], radio-allergosorbent test (RAST) [13], solid-
phase radioimmuno inhibition assay (RIA) [14], dipstick
ELISA [15], and liquid chromatography/tandem mass
spectrometry (LC/MS/MS) [16]. The DNA-based tech-
niques detect allergens by amplifying a speciﬁc DNA
fragment of a peanut allergen gene through the poly-
merase chain reaction (PCR) [17, 18]. Currently, three
DNA-based test formats are available on the market:
PCR with gel electrophoresis, DNA-ELISA, and real-
time PCR, which are qualitative kits with a detection
limit around 10–50 ppm [19, 20]. The majority of com-
mercial protein-based kits are ELISAs with the detection
limit between 0.1 and 5 ppm. Even though these assays
can precisely detect peanuts, some assays need expensive
equipment, such as a micro-plate reader or thermocy-
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cler, and all need well-trained people to operate them.
The lateral ﬂow assay is a simpliﬁed version of ELISA
with a nitrocellulose membrane strip, on which immu-
noreactants such as antibodies or antigens are applied
[21, 22]. This type of assay is easy to operate, and its
result can be visually interpreted or quantitatively
measured by densitometry with computer scanning or a
handheld reﬂectometer. Recently, only two lateral ﬂow
assays for detecting peanuts have been placed on the
market, and both are the sandwich assay format [20, 23].
In this study, a competitive lateral ﬂow assay has been
developed for speciﬁcally detecting a major peanut
allergen—Ara h1. The Ara h1 is a 63.5-kDa glycopro-
tein that comprises 12–16% of total peanut proteins,
and has a high frequency of sensitization up to 100% of
peanut-sensitized patients [24]. In addition, Ara h1 can
form a stable trimeric structure, which can protect it
from degradation due to food processing or enzymes
from the gastrointestinal tract [25, 26]. Because of this
allergenicity preservation, Ara h1 is an appropriate
marker to identify peanut contamination in foods or
production lines.
Liposomes are spherical nanovesicles composed of
one or several phospholipid bilayers surrounding an
aqueous cavity [27]. In this study, hundreds of thou-
sands of molecules of a red dye marker, sulforhodamine
B (SRB), are captured inside cavities of liposomes. This
large amount of SRB allows liposomes to be visually
detected immediately without further processing [28]. In
addition, liposomes are very stable and can be used in
ﬁeld-portable or point-of-care sensor systems [29].
Moreover, a variety of biological ligands, such as pep-
tides, hormones, antibodies, sugars, and nucleic acids,
can be conjugated to the surface of liposomes, and these
ligands make the liposomes targeted.
In this study, maleimide-modiﬁed Ara h1 molecules
were covalently conjugated to sulfhydryl groups on the
liposome surface to form Ara h1-tagged liposomes used
as the detector reagent. Free Ara h1 molecules in the
sample competed with Ara h1-tagged liposomes for
binding to the limited number of anti-Ara h1 antibodies
in the test line on the strips. Samples containing larger
amounts of Ara h1 would show lower signals on the test
line. The aim of this study was to develop and optimize a
rapid, portable, and easy-to-read lateral ﬂow assay for
the detection of the major peanut allergen—Ara h1.
Experimental
Reagents and materials
Raw peanuts were purchased from a local food market
(Geneva, NY, USA). High Q cartridge, Methyl HIC
(hydrophobic interaction chromatography) cartridge,
Protein 6 cartridge, and Protein A cartridge were
purchased from BioRad (Hercules, CA, USA).
Dipalmitoylphosphatidylcholine (DPPC), dipalmitoyl-
phosphatidylethanolamine (DPPE), dipalmitoylphos-
phatidylglycerol (DPPG), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine N-(cap biotinyl) (DPPE-biotin),
and theMini Extruder were purchased fromAvanti Polar
Lipids, Inc. (Alabaster, AL, USA). Hydroxylamine
hydrochloride, N-succinimidyl-S-acetylthiopropionate
(SATA), sulfosuccinimidyl-4-N-maleimidomethyl cyclo-
hexane-1-carboxylate (sulfo-SMCC), N-ethylmaleimide
(NEM) and Blocker Casein were purchased from Pierce
(Rockford, IL, USA). Poly(vinyl diﬂuoride) (PVDF)
membranes and HF 120 nitrocellulose (NC) membranes
were bought from Millipore (Bedford, MA, USA).
Polycarbonate (PC) membranes of 0.2- and 0.4-lm pore
size came fromWhatman International Ltd. (Maidstone,
UK). Anti-rabbit IgG (Fc fragment speciﬁc) alkaline
phosphatase conjugates and 5-bromo-4-chloro-3-indoxyl
phosphate/nitro blue tetrazolium (BCIP/NBT) sub-
strates were purchased from Promega (Madison, WI,
USA). The NC membranes (AE100, AE 99, FF 85 and
Prima 85), type 900 wicking paper, and conjugate pads
(8S, 12S, 16S and 33 Glass) were supplied by Schleicher
and Schuell (Dassel, Germany). Goat serum was from
Quad Five (Ryegate, MT, USA). All other chemicals
were purchased from Sigma (St. Louis, MO, USA).
Puriﬁcation and identiﬁcation of Ara h1
Raw peanuts were ﬁrst ground and then defatted with
acetone. Crude peanut proteins were then extracted by
mixing 40 g of the defatted peanut powder with 1 L of
extraction buﬀer (50 mM Tris, pH 8.3, 1 mM ethylene-
diaminetetraacetate (EDTA), 5 mM dithiothreitol
(DTT), 200 mMNaCl, and 0.13% v/v protease inhibitor
cocktail for plant cell extracts) at 4C for 4 h [25]. The
crude peanut proteins were puriﬁed from the 70–100%
saturated ammonium sulfate (AS) fraction, and then
dialyzed overnight against 50 mM Tris buﬀer supple-
mented with 1 mM EDTA and 5 mM DTT (pH 8.3) at
4C. The dialyzed peanut protein solution was puriﬁed in
a High Q cartridge with a linear salt gradient (0–500 mM
NaCl). Fractions containing Ara h1 were further puriﬁed
in an HIC cartridge with a linear salt gradient (2–0 M
ammonium sulfate). Protein concentration was deter-
mined by Bio-Rad protein assay with bovine serum
albumin (BSA) as the standard. Further identiﬁcation of
puriﬁed Ara h1 was investigated by N-terminal sequenc-
ing with the Edman reaction, and peptide mapping with
matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry [30]. Both analyzes
were processed by the Protein Core Facility, Johns
Hopkins University, Baltimore, MD, USA.
Production and characterization of antibodies
against Ara h1
Antibody production was carried out by AnaSpec Inc.
(San Jose, CA, USA). Two kinds of immunogens were
used to raise antibodies against Ara h1: puriﬁed Ara h1
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and peptide KLH (keyhole limpet hemocyanin). An
amount of 100 lg of puriﬁed Ara h1 was run in a so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE) gel, and the bands containing Ara h1 were
used for the immunization of two New Zealand White
rabbits (R2307 and R2308). For producing antibodies
against peptide KLH, a synthetic peptide with the se-
quence CSNREVRRYTARLKEG-NH2 was chosen
based on the expected antigenicity, synthesized, conju-
gated with KLH, and injected into two New Zealand
White rabbits (R2149 and R2150). The antibodies from
four batches of sera (R2149, R2150, R2307, and R2308)
were puriﬁed through a protein A cartridge, according
to the procedure as described by the supplier (Bio-Rad).
SDS-PAGE and Western blot
The SDS-PAGE was performed in a Bio-Rad Mini Pro-
tean II system with 10% acrylamide gel or precast 4–20%
Tris–glycine gel [31]. Gels were stained with Coomassie
Brilliant Blue G-250. For theWestern Blot, proteins from
the gel were transferred into the PVDF membrane at
100 mA for 1 h, as described by Towbin et al. [32].
Membranes were blocked with 5% (w/v) nonfat dried
milk in 10 mM Tris (pH 7.5), 150 mM NaCl, 0.05%
Tween-20 (TBST) for 1 h at room temperature. Antibody
solutions against Ara h1 were diluted to 100 ng mL1 in
TBST, and incubated with the membrane for 1 h at room
temperature. After washing with TBST, bound antibod-
ies were detected using anti-rabbit IgG conjugated to
alkaline phosphatase. The membrane was washed again
with TBST, and the captured anti-rabbit IgG complexes
were visualized by the addition of BCIP/NBT as de-
scribed by the supplier (Promega).
Indirect ELISA
In the ELISA, the microwell plate was coated with
100 lL/well of 125–500 ng mL1 Ara h1 diluted in
phosphate-buﬀered saline (PBS: 10 mM phosphate,
150 mM NaCl, pH 7.5), and incubated at 37C for 1 h.
Two hundred lL/well of 5% (w/v) BSA in TBST was
added for blocking at 37C for 1 h. After washing,
100 lL/well of 1 lg mL1 antibodies against Ara h1 was
added and incubated at 37C for 1 h. The bound anti-
bodies were detected by incubation with the diluted
1:20,000 goat anti-rabbit IgG horseradish peroxidase
(HRP) conjugators at 37C for 1 h, and then with HRP
substrate. The reaction was terminated by the addition
of 50 lL/well of 2 M H2SO4, and absorbance was
measured at 450 nm. Between each step, plates were
washed thoroughly three times with TBST.
Preparation of Ara h1-tagged liposomes
Liposomes were prepared by a hydration/freezing and
thawing/extrusion method [33]. First, DPPE-ATA was
prepared by conjugating DPPE to SATA as described
previously [34]. The mixture of DPPC, DPPG, choles-
terol, DPPE-biotin, and DPPE-ATA, in a molar ratio of
43:5:45:3:4, was dissolved in a solution of 6 mL chlo-
roform, 1 mL methanol, and 0.5 mL DPPE-ATA, and
dried on a rotary evaporator. The dried lipid ﬁlm was
hydrated by the addition of 3 mL of 0.15 M SRB
solution (in 0.02 M N-2-hydroxyethylpiperazine N-2-
ethanesulfonic acid (HEPES), pH 7.5, osmolality
535 mmol kg1). The lipid solution was processed with
ﬁve freeze/thaw cycles, and then extruded through 0.4-
and 0.2-lm pore-size PC membranes. Unencapsulated
SRB was removed by gel ﬁltration using a Sephadex G-
50 column with Tris-buﬀered saline (TBS: 0.02 M Tris
with 0.15 M NaCl, 0.01% NaN3, pH 7.5) containing
sucrose (535 mmol kg1). The phospholipid concen-
tration of the liposomes was determined by Bartlett’s
phosphorus assay [35], and the size of the liposomes was
measured by laser diﬀraction particle size analysis in an
LS particle size analyzer (Coulter Scientiﬁc Instruments,
Hialeah, FL, USA).
Ara h1-tagged liposomes were produced by conju-
gating maleimide-derivatized Ara h1 to the activated
liposomes. Brieﬂy, sulfo-SMCC was added to Ara h1 at
a molar ratio of 15/1 (sulfo-SMCC/protein), and incu-
bated at 37C for 30 min. Maleimide-derivatized Ara h1
was puriﬁed through a P6 cartridge with PBS buﬀer.
Liposomes were deprotected by 500 mM hydroxylamine
at a molar ratio of 30/1 (hydroxylamine/DPPE-ATA) at
room temperature for 2 h, and then incubated with
derivatized Ara h1 at 4C overnight. To quench the
remaining thiol groups, liposomes were treated with
100 mM N-ethylmaleimide at room temperature for 2 h.
Ara h 1-tagged liposomes were separated from unbound
Ara h1 thorough a Sepharose CL-4B column with TBS
containing sucrose (535 mmol kg1).
Preparation of test strips
The test strip consisted of a laminated card, containing a
layer of adhesive, on which the NC membrane, conju-
gate pad, and absorbent pad were pasted (Fig. 1). On a
strip, 4 lg cm1 of the antibody against Ara h1 was
coated in a test line (2.0 cm from the proximal end), and
0.5 lg cm1 avidin was coated in a control line (2.5 cm
from the proximal end) using a Linomat IV TLC
Applicator (Camag Scientiﬁc, Wrightsville Beach, NC,
USA). The membrane was dried at 37C for 30 min in a
ventilated convection oven, and stored under dry con-
ditions (desiccant) at room temperature until used. The
conjugate pad was pre-treated with a mixture of 5 mM
sodium tetraborate, 4% BSA, 3% goat serum, 1% PVP
[poly(vinyl pyrrolidone), MW 10 kDa], and 0.002%
Triton X-100 (pH 8.0) for 5 min, and then dried at 37C
for 1 h. In all assays, Schleicher and Schuell (S&S) type
900 cotton linter paper was used as the absorbent pad.
In assembling, the NC membrane was ﬁrst attached to a
laminated card and rolled to remove trapped air by
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using a small wooden brayer. The absorbent pad was
adhered to the upper end of the test strip with 0.1 cm
overlapping the NC membrane. The blocked conjugate
pad was placed at the opposite end of the test strip with
0.3 cm overlapping the NC membrane. After assem-
bling, the whole set of components was cut into 5-mm
strips.
Assay format
The sample solution (20 lL) was placed in a glass tube
(12 · 75 mm), and then a test strip was inserted into this
tube. After sample solution was absorbed (about 2 min),
a mixture of 10 lL Ara h1-tagged liposomes and 10 lL
Blocker Casein (1% casein in TBS) was added to the
same glass tube allowed to be absorbed, followed by the
addition of 50 lL Blocker Casein. Once the Blocker
Casein solution was absorbed into the strip (about
20 min), the test strip was taken out. The signal intensity
of the test line was qualitatively estimated visually, or
quantitatively measured by conversion into gray scale
readings. First, the test strips were scanned using an
Epson Expression 636 color image scanner (Torrance,
CA, USA), and the scanned images were converted into
gray scale readings by Scan analysis densitometry soft-
ware (Biosoft, Ferguson, MO, USA). When the assay is
performed properly, the control line is always visible
above the test line.
Results and discussion
Puriﬁcation and identiﬁcation of Ara h1
In 1916, Johns and Jones isolated two globulins from
peanuts by AS fractional precipitation, and named them
as arachin and conarachin [36]. More than seven decades
later, Burks and his colleagues isolated, puriﬁed, and
characterized a major peanut allergen—Ara h1 [37]. In
this study, the modiﬁed Burks’ method was used to
isolate Ara h1 from raw peanuts. The puriﬁcation of Ara
h1 was monitored by SDS-PAGE as displayed in Fig. 2.
During the puriﬁcation, the purity of Ara h1 (MW
63.5 kDa) increased from around 20% (lane 1) to about
95% of total peanut proteins (lane 4). The molecular
weight of this puriﬁed Ara h1 is the same as that isolated
by Burks [37].
To conﬁrm the identity of the puriﬁed Ara h1, the
band containing proteins with a molecular weight of
63.5 kDa was cut out and subjected to peptide mapping
and N-terminal sequencing. The ﬁrst theoretical amino
acid sequence of Ara h1 was published by Burks et al.
[38]. In this study, comparison of the measured and cal-
culated peptide masses resolved 33 peptides with high
match score (2.342·1011). These peptides covered 43% of
deduced amino acid sequence of clone P41B precursor of
Ara h1, as shown in Fig. 3. This ﬁgure also indicated the
Fig. 1 Competitive lateral ﬂow assay format. a Diagram of a test
strip showing a side-view of its components. b Principle of a
competitive test strip assay with Ara h1-tagged liposomes
Fig. 2 SDS-PAGE of each step of the overall puriﬁcation process
of Ara h1. The puriﬁcation steps were the extraction of total peanut
proteins (lane 1), 70–100% AS fractionation (lane 2), ion-exchange
chromatography on High Q column (lane 3), and hydrophobic
interaction chromatography on HIC column (lane 4). Lane M
contained pre-stained protein standards. The gel was stained with
Coomassie brilliant blue G 250
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result of N-terminal sequencing as RSPPGERT, which
matched the N-terminal sequence of Ara h1 published by
de Jong et al. [39]. The reason why the puriﬁed Ara h1
does not contain the ﬁrst 85 residues in N-terminal of
clone P41B precursor may be due to the incomplete or
diﬀerent post-translational modiﬁcations [40].
Production and characterization of antibodies
against Ara h1
Anti-Ara h1 polyclonal antibodies were produced in
New Zealand White rabbits against two diﬀerent im-
munogens. The ﬁrst immunogen was puriﬁed Ara h1,
which was utilized in the production of antibodies
against the whole Ara h1 molecule, and designated anti-
Ara h1 antibodies (R2307 and R2308). The second
immunogen was the synthetic peptide KLH. Selection of
the optimal epitope on Ara h1 for the synthetic peptide
was based on its predicted antigenicity, IgE-binding
aﬃnity, surface probability, and secondary structure.
From the epitope prediction data utilizing the amino
acid sequence of clone P41B precursor of Ara h1 pro-
vided by AnaSpec Inc. (San Jose, CA, USA), the epitope
selection was narrowed down to two possible candi-
dates: epitope A (amino acid residues 493–507) and
epitope B (amino acid residues 603–615). The predicted
data also showed that epitope B was more antigenic than
epitope A. However, in the study of IgE-binding epi-
topes on Ara h1, epitope A is one of the four immu-
nodominant IgE-binding epitopes (amino acid residue
25–34, 65–74, 89–98, and 498–507) on Ara h1 in that
they were recognized by serum from more than 80% of
peanut allergic patients and bound more IgE than any
other Ara h1 epitope [41]. Moreover, from the structural
analysis of the IgE-binding site on Ara h1 published by
Shin et al. [42], epitope A was predicted as the b-strand
on the outer surface of C-terminal domain of Ara h1,
but epitope B was unpredictable. After all of these
comparisons, epitope A was selected to produce the
synthetic peptide KLH, and antibodies raised against
this immunogen were designated anti-peptide antibodies
(R2149 and R2150).
The speciﬁcity of these four batches of antibodies was
determined by immunoblotting (Western Blot) against
the total peanut proteins (0.5 lg/lane). In this assay, all
four batches of antibodies showed high speciﬁcity to Ara
h1, since these antibodies did not react with other peanut
proteins from the crude extract of peanuts (Fig. 4a).
However, the highest immunoreaction was observed
with anti-peptide antibody R2150. To estimate antibody
aﬃnity to Ara h1, the same four batches of antibodies
were tested in an indirect ELISA. In this assay, the
puriﬁed Ara h1 was coated in wells (50 ng/well) of mi-
crotiter plates. Antibodies against Ara h1 were added to
the coated wells, washed, and then detected by HRP-
conjugated goat anti-rabbit IgG. Similar to the Western
Blot, in this assay, anti-peptide antibodies had higher
aﬃnity to Ara h1 than anti-Ara h1 antibodies (Fig. 4b).
For the Western Blot and ELISA, the order of the
Fig. 3 Amino acid sequence of
Ara h1 from clone P41B
precursor. Amino acids written
as capital letters were identiﬁed
from N-terminal sequencing,
and the highlighted amino acids
were found by peptide mapping
analysis
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antibody’s immunoactivity to Ara h1 was R2150 >
R2149 > R2308 > R2307.
Optimization of the lateral ﬂow assay
The sensitivity of the lateral ﬂow assay for detecting
peanut allergens was investigated by studying the eﬀects
of immobilized antibody, the nature of nitrocellulose
membrane, the type of blocking solution and conjugate
pad, and the antigen molar percentage on the liposomal
surface. To optimize a lateral ﬂow assay for detection of
Ara h1, the ﬁrst approach is to select an antibody
showing the highest immunoactivity to Ara h1 from four
batches of antibodies (R2307, R2308, R2149, and
R2150). The results from Western Blot clearly showed
that all four batches of antibodies had high speciﬁcity to
Ara h1, since they did not show any cross-activity to
other crude peanut proteins (Fig. 4a). No decision on
selecting a proper batch of antibodies was made based
on antibody speciﬁcity. Therefore, all batches of anti-
bodies were tested on the NC membrane for selecting the
optimal capture antibody in the test strip preparation.
The antibodies were individually immobilized on the test
line of the test strips (Fig. 1), and their aﬃnity to Ara h1
was tested in the presence of Ara h1-tagged liposomes
used as the detector reagent. The higher signal on the
test line means the greater aﬃnity the antibody has to
Ara h1. In this assay (Fig. 5), anti-Ara h1 antibodies
(R2307 and R2308) had higher aﬃnity to Ara h1 than
anti-peptide antibodies (R2149 and R2150). Their
aﬃnity order to Ara h1 was R2307 > R2308 > R2150
> R2149. Data from this test strip assay showed con-
tradictory results to the indirect ELISA or Western Blot,
where the anti-peptide antibodies had higher aﬃnity to
Ara h1 than anti-Ara h1 antibodies. There are two
possible explanations for this contradiction. The ﬁrst
explanation is based on the diﬀerent physicochemical
conditions between the lateral ﬂow assay and conven-
tional immunoassays (Western Blot and ELISA). The
stability of the antibody was diﬀerent in solution
(Western Blot or ELISA) compared to that immobilized
on the dry NC membrane surface (Lateral ﬂow assay).
During conventional immunoassays, antibodies remain
in solution. In the test strip preparation and storage,
antibodies were subjected to additional physical condi-
tions such as dispensing and drying. These could aﬀect
antibody stability and thus result in reduced immuno-
activity. Therefore, the stability of immobilized anti-
bodies becomes a key consideration in antibody
selection for the test strip preparation [40]. The second
possible explanation is that since the anti-Ara h1 anti-
bodies (R2307 and R2308) were raised against the whole
Ara h1 molecule, they could recognize more epitopes per
Ara h1 than anti-peptide antibodies (R2149 and R2150),
which were raised against only 15 amino acids of Ara h1.
The antibody that binds more epitopes per analyte may
capture more analytes compared to the antibody that
only recognizes a small portion of an analyte. Among
these four batches of antibodies, anti-Ara h1 antibody
(R2307) had the highest aﬃnity to the antigen, and was
chosen for the further assay development.
Fig. 4 Western blot (a) and indirect-ELISA (b) of peanut proteins
incubated with four batches of antibodies against Ara h1. Western
Blot was performed with total peanut proteins (0.5 lg/lane), and
ELISA with the puriﬁed Arah1 (50 ng/well). (In panel A, ﬁrst
column contained pre-stained protein standards; second column
contained total peanut proteins stained with Coomassie brilliant
blue G 250)
Fig. 5 Immunoassay of the two anti-peptide antibodies (R2150
and R2149) and two anti-Ara h1 antibodies (R2038 and R2037)
with Ara h1-tagged liposomes as the detector reagent on the
nitrocellulose membrane test strip. Antibody (4 lg cm1) was
coated in the test line on the strip, and the signal intensity of the
immunoassay was determined by gray scale intensity (GSI) with a
computer-scanning program
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The sensitivity of a lateral ﬂow assay is dependent on
the signal intensity of the test line, and the signal
intensity is aﬀected by the coating buﬀer that is used for
dilution of the capture reagent, such as antibodies. The
coating buﬀer can inﬂuence the antibody absorption on
the membrane, the antibody immunoactivity (speciﬁcity
and stability), and the ﬂow properties of the membrane
[43]. To get the optimal coating buﬀer, the ingredients of
the coating buﬀer were investigated. Generally, the
presence of ions in the coating buﬀer can increase the
solubility of antibodies; however, ions also interfere with
electrostatic interactions between antibodies and mem-
branes, and thus have an eﬀect on assay sensitivity [44].
Two buﬀer systems were examined to investigate the ion
eﬀect: phosphate buﬀer (PB: 10 mM Na2HPO4 adjusted
to pH 7.5) and phosphate-buﬀered saline (PBS: 10 mM
Na2HPO4 with 150 mM NaCl adjusted to pH 7.5).
Combinations of PB or PBS solution with two co-pre-
cipitation agents (methanol and Tween-20) were used to
evaluate assay sensitivity. Use of small amounts of co-
precipitation agents can decrease protein solubility but
promote the adsorption of the protein onto the NC
membrane [45]. The concentration of methanol and
Tween-20 were 5% (v/v) and 0.002% (v/v), respectively.
To avoid the lysis of liposomes, only a low concentration
of Tween-20 is used. As shown in Fig. 6, all combina-
tions with additives gave higher signal intensities of the
PB system compared with those of the PBS system.
Additionally, without any additives the signal intensity
of PB system was comparable to that of PBS system.
Data from this experiment indicated that the presence of
ions could interfere with the binding between antibodies
and the NC membrane, and thus reduce the antibody
coating eﬃciency. The highest signal intensity of the test
line was obtained by using 10 mM phosphate buﬀer
with 0.002% Tween-20 (v/v). Addition of methanol,
Tween-20, or both to the PB solution had a signiﬁcantly
enhanced eﬀect on the signal intensity compared with
only the PB solution. Adequate drying of the membrane
after protein application is an important practice for
ensuring the long-term stability of the protein–mem-
brane bond [46]. Therefore, after drying, the antibody-
coated membrane was stored in a sealed bag at 4C in
the presence of dessicant.
The type of nitrocellulose membrane is the other
important factor for developing test strips. The nature of
the membrane aﬀects its capillary ﬂow properties, which
in turn aﬀects assay sensitivity, assay speciﬁcity, and test
line consistency. The capillary rate is the speed at which
a sample front moves along a membrane strip. There-
fore, a membrane with higher capillary rate requires a
shorter time to complete an assay. The major goal of this
study was to develop a rapid assay, and because of that
only membranes with higher capillary rate were chosen
to investigate their eﬀects on assay sensitivity. After the
evaluation of the NC membranes [AE 99, AE 100, FF
85, Prima 85 (S&S), HF120 (Millipore)], the Prima 85
membrane completed the assay with the shortest time,
but it showed the broadest test line. This caused a loss in
signal intensity and a decrease in assay sensitivity. In a
competitive lateral ﬂow assay, the assay sensitivity is
deﬁned as the lowest concentration of analyte that
causes a measurable decrease of the signal intensity of
the test line. Among the AE 99, AE 100, FF 85, and
HF120 NC membranes, the lowest concentration of Ara
h1 in the sample to produce a decrease in the signal
intensity was observed when using the AE 100 as the NC
membrane. Therefore, AE 100 was the most appropriate
NC membrane for this assay development.
After immobilizing anti-Ara h1 antibodies on AE 100
NC membranes, the reactive groups on the membrane
must be blocked. In this assay, the blocking solution was
applied to the conjugate pad instead of to the NC
membrane. To ﬁnd the optimal conjugate pad, several
materials were tested: non-woven 8-S, 12-S, and 16-S,
glass ﬁber 33 Glass, AccuFlow P, AccuFlow G, Accu-
Flow Plus G (S&S), and glass ﬁber paper F075-17
(Whatman). Each pad was evaluated by comparing the
signal intensity of the test lines, the distribution of Ara
h1-tagged liposomes on the pad, and the amount of Ara
h1-tagged liposomes remaining on the pad after running
the assay. The best result was achieved by using non-
woven 12-S conjugate pad (S&S). Since the components
of the blocking solution can also aﬀect assay sensitivity
by changing the capillary rate, or by blocking the
interaction between immobilized antibodies and ana-
lytes, diﬀerent combinations of frequently used blocking
materials were investigated to get the optimal blocking
solution. These materials were either ‘‘protein based’’,
such as BSA, gelatin, casein, and goat serum, or ‘‘non-
protein-based’’, such as PVP (MW 10 kDa), PVA
[poly(vinyl alcohol), MW 16 kDa], Tween-20, and Tri-
ton X-100. The results showed that there were no
Fig. 6 Eﬀect of the coating buﬀer composition on the immunoas-
say of the Ara h1-tagged liposomes with anti-Ara h1 antibody
(R2307). Antibody was coated with diﬀerent coating buﬀers on NC
membrane with density as 4 lg cm1. (PBS: 10 mM sodium
phosphate, 150 mM NaCl, pH 7.5; PB: 10 mM sodium phosphate,
pH 7.5; rom T: 0.002% (v/v) Tween 20; rom M: 5% (v/v) methanol)
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obvious diﬀerences in signal intensity of the test line
between using PVP and PVA, or between using Triton
X-100 and Tween-20. Furthermore, blocking buﬀers
with diﬀerent concentrations of Triton X-100 [0.002,
0.02, and 0.2% v/v] were tested, and signal intensity
decreased with the increasing concentration of Triton X-
100. Higher concentrations (0.02 and 0.2%) of Triton X-
100 could induce the lysis of liposomes and therefore
produce a smaller number of intact liposomes captured
on the test line. A comparison of 20 diﬀerent blocking
solutions showed the highest signal intensity, and sig-
niﬁcantly less background on the strips was obtained
with the 12-S conjugate pad blocked with the mixture of
5 mM sodium tetraborate (pH 8.0), 4% BSA, 3% goat
serum, 1% PVP, and 0.002% Triton X-100.
The aﬃnity of Ara h1-tagged liposomes, used as the
detector reagent, for the immobilized antibodies was the
ﬁnal important factor needing to be optimized. The
aﬃnity between antibody and Ara h1-tagged liposome
was aﬀected by the molar percentage (mol%) of Ara h1
on the liposomal surface. Four diﬀerent Ara h1 con-
centrations were tested: 2, 1, 0.4, and 0.1 mol%. The
signal intensity of the test line was proportional to the
molar percentage of Ara h1 on the liposome surface.
However, using 1 or 2 mol% of Ara h1-tagged lipo-
somes required a higher concentration of Ara h1 in the
sample to perform the competitive assay, and this re-
sulted in a decrease of the assay sensitivity. In addition,
the liposome with 0.1 mol% of Ara h1 on the surface
showed very weak signal in the absence of Ara h1 in the
sample, so it was not an appropriate detector reagent for
this assay. Therefore, 0.4 mol% of Ara h1 on the lipo-
somal surface was selected for use as detector reagent in
this competitive lateral ﬂow assay. Moreover, liposomes
are very stable structures. In a previous study, no sig-
niﬁcant changes in liposome stability was observed when
stored at 4C over 9 months [47].
Assay performance
The assay is based on the competition between Ara h1 in
the sample and Ara h1 tagged to liposome surface for
binding to the limited amount of anti-Ara h1 antibodies
immobilized in the test line of the NC membrane strips.
When the test strip is ﬁrst incubated with the sample,
Ara h1 molecules from the sample migrate through the
test strip, and are captured by antibodies in the test line.
After all of the sample solution migrates into the strip,
Ara h1-tagged liposomes are added into the tube, mi-
grate through the same path as the free Ara h1 mole-
cules, and are captured by the remaining immobilized
antibodies with available binding sites. However, the
more Ara h1 present in the sample, the less antigen-
binding sites of the immobilized antibodies are available
for capturing the Ara h1-tagged liposomes. Therefore,
the signal intensity of the test line is inversely propor-
tional to the amount of Ara h1 in the sample. The LOD
of this competitive lateral ﬂow assay was obtained from
the dose-response curve (Fig. 7). The signal intensities of
the test lines were measured as the gray scale intensity
(GSI) by densitometry scanning. The value of LOD was
calculated as the concentration equivalent to the mean
of the blank Ara h1 samples minus three standard
deviations (SD). From the dose-response curve, a 5-
parameter sigmoidal function was described by the fol-
lowing equation:
y ¼ 3592þ 6865:5865
1þ e x3:1470:3156½ 
h i1:535
For the data plotted, this function has an R2 value as
0.9991, and from this equation the LOD value was cal-
culated as 450 ng mL1 of Ara h1. The dynamic range
of this dose–response curve is approximately between
102 and 104 ng mL1. In addition, the visual detection
limit of this assay was about 1 lg mL1 based on the
signiﬁcant decrease of signal intensity of the test line by
observation at this concentration of Ara h1. At higher
concentrations of Ara h1 (>10 lg mL1), the test line
could not be visually observed. Therefore, the visually
determined range of this assay is about 1–10 lg mL1 of
Ara h1 in buﬀer. When the assay is performed properly,
the control line is always visible above the test line.
Conclusions
This study has developed and optimized a rapid and
sensitive lateral ﬂow assay for the detection of peanut
Fig. 7 A competitive lateral ﬂow assay with a serial dilution of Ara
h1 (0, 1 · 101; 1 · 102; 1 · 103; 1 · 104; 1 · 105 ng mL1). Dose–
response curve for Ara h1 samples generated from the test strip
assay by gray scale intensity (GSI) measurement. A 5-parameter
sigmoidal function (R2 = 0.9991) was calculated from this dose–
response curve
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allergens using Ara h1-tagged liposomes as the detector
reagent. The ﬁnal optimized format of the test strip used
AE100 (S&S) as the NC membrane, non-woven 12-S
(S&S) as the conjugate pad, and type 900 cotton linter
paper (S&S) as the absorbent pad. Among four batches
of developed antibodies against Ara h1, anti-Ara h1-
antibody (R2307) was selected based on its highest im-
munoactivity to Ara h1 in the LFA assay and no cross-
reactivity to other crude peanut proteins. It was coated
at 4 lg cm1 on NC membrane with a coating buﬀer
consisting of 10 mM phosphate buﬀer (pH 8.0) with
0.002% Tween 20. Ara h1-tagged liposomes with
0.4 mol% Ara h1 on the surface were used as the
detector reagent. This assay is rapid (completed within
30 min), and easy to use by either visual determination
or densitometry measurement of the test line using
computer scanning or a handheld reﬂectometer.
From the Ara h1 dose–response curve, the LOD of
this assay was determined to be approximately 450 ng
mL1 of Ara h1 in buﬀer. Since Ara h1 normally com-
prises about 15% of total peanut proteins, this assay can
theoretically detect peanut proteins contamination
above 3.0 lg mL1 (3 ppm). This number is comparable
to the sensitivity (5–10 ppm) of commercial lateral ﬂow
assay kits. Comparing the sensitivity of this lateral ﬂow
assay to ELISA [10] or PCR assays [17, 18], this lateral
ﬂow assay has higher LOD and simply provides a
qualitative yes/no answer. On the other hand, this lateral
ﬂow assay has the advantages of shorter assay time,
operational simplicity, and fewer requirements for
equipment compared to ELISA and PCR. Therefore,
this lateral ﬂow assay is more suitable for on-site
detection such as in food processing and distribution
facilities.
This study successfully demonstrated the potential of
using the allergen-tagged liposomes in a competitive
lateral ﬂow assay for the detection of food allergens.
Future studies will focus on testing this assay in a variety
of diﬀerent food matrices to develop sample preparation
protocols, accurately determine the LOD in various
food samples, and focus on directly immobilizing lipo-
somes on the conjugate pad to further simplify the entire
assay procedure.
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